Gene · 10549
PRDX4: peroxiredoxin 4
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PRDX4: peroxiredoxin 4. Genes, record 10549. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10549
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13162 | Peroxiredoxin-4 | 271 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents88
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 10146 | Q13162 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 10753 | Q13162 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2557 | Q13162 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7423 | Q13162 | Espacenet |
| WO 2025163153 A2 | 2025-08-07 | 45 | Q13162 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7423 | Q13162 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10146 | Q13162 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 10753 | Q13162 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 10753 | Q13162 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 10760 | Q13162 | Espacenet |
1 to 10 of 88
See all 88 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants781
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PRDX4 papers | Newest fiscal year |
|---|---|---|---|
| P30CA177558 | University of Kentucky Markey Cancer Center – Cancer Center Support Grant | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA012197 | Cancer Center Support Grant | 3 | 2025 |
| P30ES001247 | Environmental Agents as Modulators of Disease Processes | 3 | 2025 |
| R01AG044034 | Oxidative Stress and the Development of Osteoarthritis | 3 | 2025 |
| P20GM103476 | Mississippi INBRE | 2 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 781Source NIH's project files
See all 781 nih grantsPapers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on the characterization, evolution and functions of molluscan peroxiredoxins. | Dev Comp Immunol | 2026 | 42810604 | PubTator, text mining | PubMed |
| A Risk Prediction Model for Normal-Tension Glaucoma Progression Integrating Genetic Markers and Corneal Biomechanics. | Semin Ophthalmol | 2026 | 42635405 | PubTator, text mining | PubMed |
| Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma. | Ocul Oncol Pathol | 2026 | 42553888 | PubTator, text mining | PubMed |
Comparative Evaluation of Serum Peroxiredoxin 2 (PRDX2), Serum Peroxiredoxin 4 (PRDX4), and Plasma Methylated Septin 9 (mSEPT9) Levels Against Conventional Biomarkers for Early Detection of Colorectal Cancer: A Study Protocol. | Cureus | 2026 | 42404326 | PubTator, text mining | PubMed |
| Shared Transcriptomic Signatures and Network Interactions Between Lung Adenocarcinoma and Asthma. | Int J Mol Sci | 2026 | 42353258 | PubTator, text mining | PubMed |
| Bulk RNA sequencing identifies biomarkers for mitochondrial and programmed cell death in keloids. | Burns | 2026 | 42314404 | PubTator, text mining | PubMed |
| From tooth to gut: Proteomic evidence of systemic dysregulation in fluorosis. | Ecotoxicol Environ Saf | 2026 | 42202465 | PubTator, text mining | PubMed |
| Isoform-specific expression of peroxiredoxins in human cancer cell lines with various radioresistance. | Free Radic Res | 2026 | 42172000 | PubTator, text mining | PubMed |
| Iron: Regulation, redox homeostasis, and ferroptosis in cancer. | Ferroptosis Oxid Stress | 2026 | 42099806 | PubTator, text mining | PubMed |
| Serum phosphoproteome alterations associated with cardiac troponin I levels in acute myocardial infarction. | Turk J Med Sci | 2026 | 42058992 | PubTator, text mining | PubMed |
1 to 10 of 1,420
See all 1,420 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10549
GET https://conductscience.org/api/genes/v1/10549/patents?page=2